Implementing a Home Blood Pressure Monitoring Program in Primary Care
MonitorBP
2 other identifiers
interventional
23,928
1 country
2
Brief Summary
The goal of this research is to determine whether a theory-informed implementation strategy is successful at increasing the uptake of a supported home blood pressure monitoring (HBPM) program as well as to determine the effectiveness of this evidence-based practice when implemented across multiple practices serving a diverse patient population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable hypertension
Started Nov 2023
Typical duration for not_applicable hypertension
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 23, 2023
CompletedFirst Posted
Study publicly available on registry
June 2, 2023
CompletedStudy Start
First participant enrolled
November 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
March 11, 2026
March 1, 2026
3 years
May 23, 2023
March 9, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in patient's office systolic blood pressure (SBP)
Change in patient's office systolic blood pressure (SBP) from index visit to last visit during the subsequent 12 months, among patients with uncontrolled hypertension at the index visit
12 months
Secondary Outcomes (4)
Office diastolic blood pressure (DBP)
12 months
Change in patient's antihypertensive medication regimen intensity
12 months
Antihypertensive medication adherence
12 months
Uncontrolled hypertension
12 months
Study Arms (4)
Intervention Clinics, Pre-Implementation Period
EXPERIMENTALUsual care
Intervention Clinics, Post-Implementation Period
EXPERIMENTALAccess to Supported HBPM program plus a multifaceted implementation strategy designed to increase uptake of the program by primary care patients with uncontrolled hypertension
Control Clinics, Pre-Implementation Period
OTHERUsual care
Control Clinics, Post-Implementation Period
OTHERUsual care
Interventions
Supported HBPM Program: * Patients are loaned a wireless home BP device or use their own device * Navigator or app support for onboarding and engaging patients in HBPM * Nursing or app support for monitoring and triaging home BP data for extreme readings * EHR integration of order for program and home BP data, with weekly feedback of home BP results to clinicians within the EHR Multifaceted implementation strategy: * Clinician education about the benefits of the program as well as training in how to refer and manage patients who are enrolled * Prompts and reminders to increase clinician referrals * Instructional materials for patients and clinicians * Problem-solving meetings to tailor implementation for individual practices
Usual care
Eligibility Criteria
You may qualify if:
- Hypertension (as per International Statistical Classification of Diseases and Related Health Problems (ICD)-10 codes)
- At least one completed primary care office visit during relevant 6-month pre implementation or post-implementation study time period
- Age 18-85 years old
You may not qualify if:
- Advanced dementia or other measure of frailty (as per ICD-10 codes)
- Pregnancy during measurement period (as per ICD-10 codes)
- Stage 5 or end-stage kidney disease (as per ICD-10 codes)
- Terminal illness/in hospice care (as per ICD-10 codes)
- Practice-level
- Primary care practice that provides care to adult patients affiliated with New York Presbyterian's Ambulatory Care Network, ColumbiaDoctors, or Weill Cornell Medicine, including practices that specialize in HIV medicine
- Medical director declines participation in the trial
- Site for pilot testing the supported HBPM program or its implementation strategy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Columbia Universitylead
- New York Presbyterian Hospitalcollaborator
- Weill Medical College of Cornell Universitycollaborator
- National Heart, Lung, and Blood Institute (NHLBI)collaborator
Study Sites (2)
Columbia University Irving Medical Center
New York, New York, 10032, United States
Weill Medical College of Cornell University
New York, New York, 10065, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ian Kronish, MD
Columbia University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Data analysts will be blinded to group assignment when analyzing electronic health record data to determine the effectiveness of the program.
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Medicine at CUIMC, Associate Director of the Center for Behavioral Cardiovascular Health
Study Record Dates
First Submitted
May 23, 2023
First Posted
June 2, 2023
Study Start
November 1, 2023
Primary Completion (Estimated)
November 1, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
March 11, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- After completion of major study activities.
- Access Criteria
- Access to the data archive will be provided upon request
A de-identified data archive that contains raw study data will be posted on an open science platform.